Annexon Biosciences (ANNX)
US Market

Annexon Biosciences Financial Statements

Annexon Biosciences Financial Overview

Annexon Biosciences's market cap is currently ―. The company's EPS TTM is $-3.63; its P/E ratio is -1.07; Annexon Biosciences is scheduled to report earnings on August 15, 2022, and the estimated EPS forecast is $-0.94. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -35.43M$ -37.46M$ -35.68M$ -31.37M$ -26.20M
EBITDA$ -34.91M$ -36.95M$ -35.12M$ -30.84M$ -25.66M
Net Income Common Stockholders$ -35.37M$ -37.37M$ -35.60M$ -31.29M$ -26.06M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 206.66M$ 242.72M$ 271.37M$ 302.39M$ 326.65M
Total Assets$ 250.57M$ 287.04M$ 310.16M$ 331.78M$ 333.12M
Total Debt$ 63.00K$ 26.41M$ 34.10M$ 34.66M$ 33.76M
Net Debt$ -206.60M$ -216.30M$ -237.26M$ -267.72M$ -292.89M
Total Liabilities$ 49.95M$ 55.13M$ 45.68M$ 36.45M$ 11.64M
Stockholders Equity$ 200.61M$ 231.91M$ 264.48M$ 295.33M$ 321.48M
Cash Flow
Free Cash Flow$ -35.50M$ -29.18M$ -30.48M$ -24.63M$ -23.47M
Operating Cash Flow$ -30.29M$ -28.32M$ -29.71M$ -24.63M$ -23.44M
Investing Cash Flow$ 68.25M$ 33.70M$ -1.28M$ -83.07M$ -37.58M
Financing Cash Flow$ 19.00K$ 948.00K$ -73.00K$ 652.00K$ 268.00K
Currency in USD

Annexon Biosciences Earnings and Revenue History

Annexon Biosciences Debt to Assets

Annexon Biosciences Cash Flow

Annexon Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis